Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
PanChol
BIOLOGICAL
2 trials
Sponsors
Brigham and Women's Hospital
, Centre for Infectious Disease Research in Zambia
Conditions
Cholera
Cholera Vaccination Reaction
Cholera Vaccine Toxicity
Phase 1
First in Human Phase 1 Ascending Dose Study of PanChol in Healthy Volunteers
NCT05657782
Brigham and Women's Hospital
Cholera, Cholera Vaccine Toxicity
Start: 2022-12-12
End: 2025-12-01
Target: 53
Updated: 2022-12-20
Phase 1b Ascending Dose Study of PanChol in Healthy Volunteers
Recruiting
NCT07107516
Centre for Infectious Disease Research in Zambia
Cholera Vaccination Reaction
Start: 2026-05-20
End: 2027-01-31
Target: 32
Updated: 2026-07-29
Related Papers
Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomised, placebo-controlled trial.
2026-01-07